Blair promises U-turn on asbestos-death payouts
Edinburgh Evening News - Jun 13 5:57 AM
TONY Blair has promised to reverse a Law Lords Ruling that prevents families receiving full compensation for asbestos- related deaths.Save to My Web
Employers warn PM over holiday pledge
Guardian Unlimited - Jun 13 7:12 PM
UK employers today warned Tony Blair that a commitment given today to extend holidays for more than 2 million workers should be stalled for at least 18 months.Save to My Web
Encouraging Phase I Trial Results for XL647 in Patients with Advanced Solid Malignancies Presented at ASCO
[Press Release] PR Newswire via Yahoo! Finance - Jun 03 5:01 AM
Exelixis, Inc. announces that updated results from a Phase I trial of XL647 in patients with advanced solid malignancies were reported today. XL647 is an orally bioavailable small molecule inhibitor of HER2, EGFR, VEGFR and EphB4.Save to My Web
Clinical Trial Confirms Novel EGFR Antibody Targets Tumors But Not Normal Tissues
Medical News Today - Jun 06 12:10 AM
The Ludwig Institute for Cancer Research (LICR) and Life Science Pharmaceuticals (LSP) today announced the results of the first clinical trial of monoclonal antibody (mAb) 806, which demonstrate that 806 specifically targets epidermal growth factor receptor (EGFR) on a wide range of tumor types but has no uptake by normal tissues. [click link for full article]Save to My Web
Baywatch - on tour
BBC News - Jun 07 9:14 AM
BBC Wales’ political reporter Adrian Masters keeps an eye on all things Welsh at Westminster.Save to My Web
Lilly Breast Cancer Studies Explore Potential Role Of Pharmacogenomics In Customizing Chemotherapy
Medical News Today - Jun 04 12:11 AM
At the 42nd American Societyof Clinical Oncology (ASCO) annual meeting in Atlanta, Ga., Eli Lilly andCompany, a leader in thoracic cancer, unveiled two breast cancer studiesinvolving pharmacogenomics and its chemotherapies GEMZAR(R) (gemcitabineHCl) and ALIMTA(R) (pemetrexed). [click link for full article]Save to My Web